Mitogen-activated protein kinases (MAPKs), including p-ERK, have been suggested to play a key role in inducing and maintaining peripheral and central sensitisation, not only in neuropathic pain but also in migraine [18, 19]. Here, WNK2 is linked to migraine disorder.